Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Austin D Williams

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Annals of Surgical Oncology|August 23, 2025
Management and Outcomes in Patients with Breast Cancer with 1-of-1 and 2-of-2 Positive Sentinel NodesWalker Lyons, E McAuley Fish, Richard J Bleicher, et al.
Annals of Surgical Oncology|July 8, 2024
Nodal Surgery for Patients ≥ 70 Undergoing Mastectomy for DCIS? Choose WiselyElissa C Dalton, Cecilia Chang, Cassandra Cardarelli, et al.
Cancer|November 29, 2023
Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?Austin D Williams, Karen Ruth, Saba S Shaikh, et al.
Annals of Surgical Oncology|October 12, 2021
Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus PandemicAustin D Williams, Cecilia Chang, Elin R Sigurdson, et al.
The Journal of Surgical Research|May 28, 2024
Lost in Translation: Multilingual Analysis of Online Breast Cancer InformationTerry P Gao, Kristen M HoSang, Dianelys Tabla Cendra, et al.
The Journal of Surgical Research|May 22, 2024
What Proportion of BRCA-Associated Breast Cancer Is Human Epidermal Growth Factor 2-Low and Eligible for Additional Targeted Therapy?Emily Forester, Aakash Belsare, Dong Won Kim, et al.
Annals of Surgical Oncology|December 3, 2024
ASO Visual Abstract: Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2 Overexpressing Breast CancersLeah Winer, Karen J Ruth, Richard J Bleicher, et al.
Annals of Surgical Oncology|November 9, 2024
Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2-Overexpressing Breast CancersLeah Winer, Karen J Ruth, Richard J Bleicher, et al.
The Journal of Surgical Research|August 4, 2024
A Bilingual Readability Assessment of Online Breast Cancer Screening and Treatment InformationDianelys Tabla Cendra, Terry P Gao, Kristen M HoSang, et al.
Journal of the American College of Surgeons|June 27, 2025
Bridging the Gap: Enhancing First-Year Education Through the Surgical Ethics and Application for Medical Students ProgramAustin D Williams, Bhavana Kunisetty, Nicolas Restrepo, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Annals of Surgical Oncology|August 23, 2025
Management and Outcomes in Patients with Breast Cancer with 1-of-1 and 2-of-2 Positive Sentinel NodesWalker Lyons, E McAuley Fish, Richard J Bleicher, et al.
Annals of Surgical Oncology|July 8, 2024
Nodal Surgery for Patients ≥ 70 Undergoing Mastectomy for DCIS? Choose WiselyElissa C Dalton, Cecilia Chang, Cassandra Cardarelli, et al.
Cancer|November 29, 2023
Should patients with hormone receptor-positive, HER2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib?Austin D Williams, Karen Ruth, Saba S Shaikh, et al.
Annals of Surgical Oncology|October 12, 2021
Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus PandemicAustin D Williams, Cecilia Chang, Elin R Sigurdson, et al.
The Journal of Surgical Research|May 28, 2024
Lost in Translation: Multilingual Analysis of Online Breast Cancer InformationTerry P Gao, Kristen M HoSang, Dianelys Tabla Cendra, et al.
The Journal of Surgical Research|May 22, 2024
What Proportion of BRCA-Associated Breast Cancer Is Human Epidermal Growth Factor 2-Low and Eligible for Additional Targeted Therapy?Emily Forester, Aakash Belsare, Dong Won Kim, et al.
Annals of Surgical Oncology|December 3, 2024
ASO Visual Abstract: Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2 Overexpressing Breast CancersLeah Winer, Karen J Ruth, Richard J Bleicher, et al.
Annals of Surgical Oncology|November 9, 2024
Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2-Overexpressing Breast CancersLeah Winer, Karen J Ruth, Richard J Bleicher, et al.
The Journal of Surgical Research|August 4, 2024
A Bilingual Readability Assessment of Online Breast Cancer Screening and Treatment InformationDianelys Tabla Cendra, Terry P Gao, Kristen M HoSang, et al.
Journal of the American College of Surgeons|June 27, 2025
Bridging the Gap: Enhancing First-Year Education Through the Surgical Ethics and Application for Medical Students ProgramAustin D Williams, Bhavana Kunisetty, Nicolas Restrepo, et al.
Pageof 8